Vensana Capital

Vensana Capital investment thesis

Justin Klein is a co-founder and Managing Partner at Vensana Capital, a leading venture capital and growth equity firm dedicated to medtech innovation. Justin currently or previously served on the board of directors of Abrus Bio, Apella, Cartiva (acquired), ChromaCode, Cleerly, Curate BioSciences, CV Ingenuity (acquired), Epix Therapeutics (acquired), Evident Vascular, Intact Vascular (acquired), Luna Diabetes, Personal Genome Diagnostics (acquired), PhaseBio Pharmaceuticals (IPO), Relievant Medsystems (acquired), Senseonics (IPO), Topera (acquired), Ulthera (acquired), Ventaris Surgical, Vertiflex (acquired), Vesper Medical (acquired), Volta Medical, and VytronUS (acquired). Justin currently serves as a member of the board of directors of the Medical Device Manufacturers Association and t

Vensana Capital team (6)

Partners and principals at Vensana Capital:

• Greg Banker — sweet spot $25M
• Justin Klein — sweet spot $25M
• Mike Kramer — sweet spot $25M
• Kirk Nielsen — sweet spot $25M
• Amrinder Singh — sweet spot $25M
• Cynthia Yee — sweet spot $25M

Is Vensana Capital a fit for your round?

Upload your pitch deck and see whether anyone at Vensana Capital appears in your top matches.